Evaluation of Deuterium-Labeled JNJ38877605: Pharmacokinetic, Metabolic, and in Vivo Antitumor Profiles

Abstract

c-Met inhibitor JNJ38877605 has proven curative as an antitumor agent, while its clinical study was terminated due to renal toxicity. It was reported that the renal toxicity was caused by the poor solubility of its aldehyde oxidase (AO) metabolites. Therefore, blocking AO oxidation of JNJ38877605 might diminish the toxic metabolites and overcome the renal toxicity. Compound 3, the AO metabolic site deuterated JNJ38877605, was then synthesized as the target molecule. In vitro monkey liver S9 fraction incubation of 3 manifested that the renal toxic metabolite M2-2 was significantly reduced, which connoted that this deuteration has partly blocked AO oxidation. After po. nasal gavage to cynomolgus monkeys, compound 3 revealed decreased AO metabolites M2-2 and M3-2 in the plasma as well as 1.88-fold AUC and 1.56-fold C max compared with JNJ38877605, indicating that deuterium replacement significantly blocked AO metabolism in vivo. Besides, metabolic profiles of 3 were investigated by analysis of the plasma and the urine of the po. administrated cynomolgus monkeys. Moreover, after oral administration to the EBC-1 tumor-bearing nude mice, compound 3 exhibited a better antitumor efficacy than JNJ38877605. In conclusion, deuteration on the AO metabolic site of JNJ38877605 improved its AO metabolism, oral exposure, as well as in vivo antitumor efficacy.

Phase I clinical trial of HC‐1119 soft capsule in Chinese healthy adult male subjects: Pharmacokinetics and safety of single‐dose proportionality and effects of food

“…More energy is needed to break the C–D bond than the C–H bond cleavage. Thus, the metabolic process of the deuterated compounds under the catalysis of cytochrome P450, monoamine oxidase or aldehyde oxidase will be slowed down when the C‐H bond participates in the rate determining step of the metabolic pathway 19,20 . This is the most expected isotopic effect for deuterated enzalutamide to carry higher resistance to enzyme oxidation.…”

Advanced Synthesis Using Photocatalysis Involved Dual Catalytic System

“…Lewis The aromatic hydrogen atom substituted by a monodeuterium is an effective method to optimize the metabolism of drug molecules, which is beneficial to the production of high-value new drugs. [136] However, the introduction of deuterium into structurally complexed aromatic rings remains a challenge. Therefore, the development of a general method with excellent deuterium incorporation and functional group tolerance using D 2 O as an inexpensive deuterium source is highly desirable.…”

“…The aromatic hydrogen atom substituted by a monodeuterium is an effective method to optimize the metabolism of drug molecules, which is beneficial to the production of high‐value new drugs [136] . However, the introduction of deuterium into structurally complexed aromatic rings remains a challenge.…”

Into the Fray! A Beginner's Guide to Medicinal Chemistry

“…This modification had the added benefit of increasing drug exposure following oral dosing, and improving antitumor activity, in nonhuman in vivo models. [102]…”